par Ziotopoulos, Panagiotis;Androulakis, Nikolaos;Mylonaki, Efthimia;Chandrinos, Vassilios;Zachariadis, Emmanouel;Boukovinas, Ioannis;Agelidou, Athina;Kentepozidis, Nikolaos;Ignatiadis, Michail ;Vossos, Andreas;Georgoulias, Vassilis;Lung Cancer Committee of the Hellenic Oncology Research Group (HORG),
Référence Lung cancer, 50, 1, page (115-122)
Publication Publié, 2005-10
Référence Lung cancer, 50, 1, page (115-122)
Publication Publié, 2005-10
Article révisé par les pairs
Titre: |
|
Auteur: | Ziotopoulos, Panagiotis; Androulakis, Nikolaos; Mylonaki, Efthimia; Chandrinos, Vassilios; Zachariadis, Emmanouel; Boukovinas, Ioannis; Agelidou, Athina; Kentepozidis, Nikolaos; Ignatiadis, Michail; Vossos, Andreas; Georgoulias, Vassilis; Lung Cancer Committee of the Hellenic Oncology Research Group (HORG), |
Informations sur la publication: | Lung cancer, 50, 1, page (115-122) |
Statut de publication: | Publié, 2005-10 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Cancérologie | |
Médecine pathologie humaine | |
MeSH keywords: | Adult |
Aged | |
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
Camptothecin -- administration & dosage -- analogs & derivatives | |
Carcinoma, Non-Small-Cell Lung -- drug therapy -- pathology | |
Disease Progression | |
Female | |
Granulocyte Colony-Stimulating Factor -- administration & dosage | |
Humans | |
Infusions, Intravenous | |
Lung Neoplasms -- drug therapy -- pathology | |
Male | |
Middle Aged | |
Neutropenia -- chemically induced | |
Survival Analysis | |
Taxoids -- administration & dosage | |
Treatment Outcome | |
Langue: | Anglais |
Identificateurs: | urn:issn:0169-5002 |
info:doi/10.1016/j.lungcan.2005.05.004 | |
info:pii/S0169-5002(05)00243-6 | |
info:pmid/15993981 |